Congressional Stock Trades & Disclosures
Jefferson Shreve is a U.S. Representative, a Republican representing IN. As of June 2026, Bullish Whales has tracked 636 disclosed stock trades across 255 companies, representing $238M in disclosed transaction value, each filed publicly under the STOCK Act.
About Shreve's congressional trading
Shreve's disclosed activity shows a sell-leaning pattern, with 207 purchases and 427 sales (a buy-to-sell ratio of 0.48). Shreve has traded --, BLK, and HAL most frequently among disclosed positions.
On the Quantellect Score, which ranks members of Congress by the estimated results of their disclosed buys over the last 12 months relative to peers, Shreve rates 94 out of 100, a Elite reading. The score weights estimated total profit, profit relative to the S&P 500, and win rate, all estimated from public filings; it is a descriptive research signal, not investment advice or an allegation of unlawful trading.
Over the trailing 12 months, Shreve's disclosed buys show an estimated unrealized profit of $5.1 million, based on 223 of 223 priced disclosed buys through July 14, 2026. These are estimates from disclosed amount ranges marked to the latest close; they do not net later sales, taxes, or fees, and are not an allegation of wrongdoing.
Shreve's most recent disclosed trade was a purchase of JP Morgan 3-Year Auto Callable Buffer Note INDU/NDX/RTY- May 2026 [CS] (--) from May 2026. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Estimated trading profits
No priced buy disclosures in this window.
Based on 223 of 223 disclosed buys with pricing coverage.
Jul 15, 2025 to Jul 14, 2026
Based on 225 of 225 disclosed buys with pricing coverage.
May 8, 2015 to Jul 14, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 --JP Morgan 3-Year Auto Callable Buffer Note INDU/NDX/RTY- May 2026 [CS] | Buy | $5,000,001 - $25,000,000 | 20 MAY 2026 | N/A | — |
| --Morgan Stanley 37-Month One-time Callable Note INDU/SPX - May 2026 [CS] | Buy | $1,000,001 - $5,000,000 | 20 MAY 2026 | N/A | — |
| --Prudential RILA - 10% Buffer 6-year Alliance Bernstein 500 Plus Index with participation rate [VA] | Buy | $1,000,001 - $5,000,000 | 17 FEB 2026 | N/A | — |
| --Prudential RILA - 10% Buffer 3-year Alliance Bernstein 500 Plus Index [VA] | Buy | $1,000,001 - $5,000,000 | 17 FEB 2026 | N/A | — |
| --Prudential RILA - 10% Buffer 3-year S&P 500 Index [VA] | Buy | $1,000,001 - $5,000,000 | 17 FEB 2026 | N/A | — |
| --Brighthouse Buffered Annuity S&P 500 Trigger Rate [VA] | Sell | $5,000,001 - $25,000,000 | 09 FEB 2026 | N/A | — |
| --Brighthouse Buffered Annuity Russell 2000 Cap Rate [VA] | Sell | $5,000,001 - $25,000,000 | 09 FEB 2026 | N/A | — |
| --JP Morgan 3-year auto callable buffer note [CS] | Buy | $5,000,001 - $25,000,000 | 30 DEC 2025 | N/A | — |
| --JP Morgan 3-year one-time callable barrier note [CS] | Buy | $5,000,001 - $25,000,000 | 30 DEC 2025 | N/A | — |
| --JP Morgan 3-year auto callable buffer note [CS] | Buy | $5,000,001 - $25,000,000 | 30 DEC 2025 | N/A | — |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Jefferson Shreve congressional trading FAQ
Can Jefferson Shreve legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Jefferson Shreve's disclosures so the public can review them.
Where does Quantellect get Jefferson Shreve's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Jefferson Shreve's stock trades?
Quantellect tracks every stock trade Jefferson Shreve discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Jefferson Shreve disclosed?
Quantellect has tracked 636 disclosed trades by Jefferson Shreve across 255 companies.
Which stocks does Jefferson Shreve trade most?
Jefferson Shreve's most frequently disclosed positions include --, BLK, HAL, TXN, and AMAT. The full list of companies and individual filings is shown on this page.
What was Jefferson Shreve's most recent stock trade?
Jefferson Shreve most recently bought JP Morgan 3-Year Auto Callable Buffer Note INDU/NDX/RTY- May 2026 [CS] (--) in May 2026, according to public STOCK Act filings tracked by Quantellect.
What is Jefferson Shreve's Quantellect Score?
Jefferson Shreve has a Quantellect Score of 94 out of 100 (Elite). The score ranks members by the estimated results of their disclosed buys over the last 12 months, weighting estimated total profit, profit versus the S&P 500, and win rate. It is a descriptive research signal, not investment advice or an allegation of unlawful trading.
How much has Jefferson Shreve made trading stocks?
Quantellect estimates Jefferson Shreve's disclosed buys show an estimated unrealized profit of $5.1 million over the trailing 12 months, based on priced disclosed buy transactions through July 14, 2026. This is an estimate and does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. It is descriptive research, not investment advice or an allegation of wrongdoing.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.